Smallcap momentum portfolio

Update for entry on 28th October 2024 (lookback dates: 27/10/2023 and 26/04/2024)

50EMA (17,938) > 200EMA (16,334); hence, we can continue without any change.

Based on ranking:

1. GET&D
2. SUVENPHAR
3. GLENMARK
4. MCX
5. BASF
6. PPLPHARMA
7. ANANTRAJ
8. NETWEB
9. JUBLPHARMA
10. GODFRYPHLP
11. MOTILALOFS
12. INOXWIND
13. BIKAJI
14. KAYNES
15. HSCL
16. POLYMED
17. TECHNOE
18. CHOLAHLDNG
19. ERIS
20. PCBL

Based on A → Z for easy tracking:

• ANANTRAJ
• BASF
• BIKAJI*
• CHOLAHLDNG
• ERIS
• GET&D
• GLENMARK
• GODFRYPHLP
• HSCL
• INOXWIND
• JUBLPHARMA
• KAYNES
• MCX
• MOTILALOFS
• NETWEB
• PCBL
• POLYMED*
• PPLPHARMA
• SUVENPHAR
• TECHNOE

Exits:
NEWGEN makes an exit.
DOMS stays within the top 25 and hence remains.

Entries:
BIKAJI makes an entry.
POLYMED cannot enter as there is no vacancy.